A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years

Clinical trial NCT04899336 · COMPLETED

Trial details

NCT number: NCT04899336
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

Start date: 2021-06-30
Primary completion: 2025-08-27
Enrollment: 17797

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.